Cargando…
Revolution or redux? Assessing IQOS through a precursor product
BACKGROUND: Philip Morris International (PMI) currently claims that its heated tobacco product, IQOS, reduces health risk by reducing users’ exposure to harmful and potentially harmful constituents present in tobacco smoke. Given the tobacco industry’s long history of misrepresenting and obfuscating...
Autores principales: | Elias, Jesse, Dutra, Lauren M, St. Helen, Gideon, Ling, Pamela M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238084/ https://www.ncbi.nlm.nih.gov/pubmed/30305324 http://dx.doi.org/10.1136/tobaccocontrol-2018-054327 |
Ejemplares similares
-
IQOS labelling will mislead consumers
por: McKelvey, Karma, et al.
Publicado: (2018) -
IQOS: examination of Philip Morris International’s claim of reduced exposure
por: St.Helen, Gideon, et al.
Publicado: (2018) -
Assessment of industry data on pulmonary and immunosuppressive effects of IQOS
por: Moazed, Farzad, et al.
Publicado: (2018) -
Humble Behaviorism Redux
por: Kirby, Megan S., et al.
Publicado: (2022) -
Possible hepatotoxicity of IQOS
por: Chun, Lauren, et al.
Publicado: (2018)